nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—ALDH1A1—kidney cancer	0.254	0.552	CbGaD
Tretinoin—CRABP1—kidney cancer	0.176	0.383	CbGaD
Tretinoin—NR0B1—Vincristine—kidney cancer	0.0861	0.288	CbGbCtD
Tretinoin—CYP1A1—kidney cancer	0.0299	0.065	CbGaD
Tretinoin—CYP3A7—Temsirolimus—kidney cancer	0.0204	0.0682	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0204	0.0682	CbGbCtD
Tretinoin—CYP3A5—Temsirolimus—kidney cancer	0.0153	0.0511	CbGbCtD
Tretinoin—CYP1A1—Erlotinib—kidney cancer	0.00955	0.0319	CbGbCtD
Tretinoin—CYP3A4—Everolimus—kidney cancer	0.00882	0.0295	CbGbCtD
Tretinoin—CYP2C8—Pazopanib—kidney cancer	0.00772	0.0258	CbGbCtD
Tretinoin—CYP3A7—Paclitaxel—kidney cancer	0.00699	0.0234	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00699	0.0234	CbGbCtD
Tretinoin—CYP3A7—Sorafenib—kidney cancer	0.00621	0.0208	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00621	0.0208	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00603	0.0202	CbGbCtD
Tretinoin—CYP3A7—Vincristine—kidney cancer	0.00603	0.0202	CbGbCtD
Tretinoin—CYP3A4—Temsirolimus—kidney cancer	0.00596	0.0199	CbGbCtD
Tretinoin—CYP2B6—Sorafenib—kidney cancer	0.00591	0.0198	CbGbCtD
Tretinoin—CYP3A5—Erlotinib—kidney cancer	0.00573	0.0192	CbGbCtD
Tretinoin—CYP2C9—Capecitabine—kidney cancer	0.00562	0.0188	CbGbCtD
Tretinoin—CYP2C8—Erlotinib—kidney cancer	0.00551	0.0184	CbGbCtD
Tretinoin—CYP3A5—Paclitaxel—kidney cancer	0.00524	0.0176	CbGbCtD
Tretinoin—CYP2C8—Paclitaxel—kidney cancer	0.00504	0.0169	CbGbCtD
Tretinoin—CYP3A7—Sunitinib—kidney cancer	0.00503	0.0168	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00503	0.0168	CbGbCtD
Tretinoin—CYP3A5—Sorafenib—kidney cancer	0.00466	0.0156	CbGbCtD
Tretinoin—CYP3A5—Vincristine—kidney cancer	0.00452	0.0151	CbGbCtD
Tretinoin—CYP2C8—Sorafenib—kidney cancer	0.00448	0.015	CbGbCtD
Tretinoin—CYP3A5—Sunitinib—kidney cancer	0.00377	0.0126	CbGbCtD
Tretinoin—CYP2B6—Doxorubicin—kidney cancer	0.00359	0.012	CbGbCtD
Tretinoin—CYP2C9—Paclitaxel—kidney cancer	0.00352	0.0118	CbGbCtD
Tretinoin—CYP3A4—Pazopanib—kidney cancer	0.00313	0.0105	CbGbCtD
Tretinoin—CYP2C9—Sorafenib—kidney cancer	0.00312	0.0105	CbGbCtD
Tretinoin—GPRC5A—renal system—kidney cancer	0.00286	0.0845	CbGeAlD
Tretinoin—GPRC5A—kidney—kidney cancer	0.00276	0.0817	CbGeAlD
Tretinoin—CYP3A4—Erlotinib—kidney cancer	0.00223	0.00748	CbGbCtD
Tretinoin—CYP3A4—Paclitaxel—kidney cancer	0.00205	0.00684	CbGbCtD
Tretinoin—CYP3A4—Sorafenib—kidney cancer	0.00182	0.00608	CbGbCtD
Tretinoin—CYP3A4—Vinblastine—kidney cancer	0.00179	0.006	CbGbCtD
Tretinoin—CYP3A4—Vincristine—kidney cancer	0.00176	0.0059	CbGbCtD
Tretinoin—CYP3A4—Sunitinib—kidney cancer	0.00147	0.00493	CbGbCtD
Tretinoin—Vitamin A—ALDH1A1—kidney cancer	0.00144	0.464	CrCbGaD
Tretinoin—Alitretinoin—CRABP1—kidney cancer	0.00137	0.441	CrCbGaD
Tretinoin—RARRES1—cardiac atrium—kidney cancer	0.00129	0.0383	CbGeAlD
Tretinoin—ALDH1A2—nephron tubule—kidney cancer	0.00122	0.0361	CbGeAlD
Tretinoin—NR0B1—gonad—kidney cancer	0.00112	0.033	CbGeAlD
Tretinoin—ALDH1A2—renal system—kidney cancer	0.00111	0.0328	CbGeAlD
Tretinoin—CYP3A4—Doxorubicin—kidney cancer	0.0011	0.00369	CbGbCtD
Tretinoin—CYP4A11—renal system—kidney cancer	0.00107	0.0316	CbGeAlD
Tretinoin—ALDH1A2—cortex of kidney—kidney cancer	0.00104	0.0309	CbGeAlD
Tretinoin—CYP4A11—kidney—kidney cancer	0.00103	0.0306	CbGeAlD
Tretinoin—CRABP1—cortex of kidney—kidney cancer	0.00101	0.0298	CbGeAlD
Tretinoin—CYP4A11—cortex of kidney—kidney cancer	0.00101	0.0298	CbGeAlD
Tretinoin—ALDH1A2—gonad—kidney cancer	0.000994	0.0294	CbGeAlD
Tretinoin—RXRA—renal system—kidney cancer	0.000963	0.0285	CbGeAlD
Tretinoin—CRABP1—gonad—kidney cancer	0.000959	0.0284	CbGeAlD
Tretinoin—CYP2C9—urine—kidney cancer	0.000954	0.0282	CbGeAlD
Tretinoin—RXRA—kidney—kidney cancer	0.000931	0.0275	CbGeAlD
Tretinoin—ALDH1A1—Vinblastine—Vincristine—kidney cancer	0.000895	0.588	CbGdCrCtD
Tretinoin—ALDH1A1—nephron tubule—kidney cancer	0.000887	0.0262	CbGeAlD
Tretinoin—CRABP2—gonad—kidney cancer	0.000868	0.0256	CbGeAlD
Tretinoin—ALDH1A1—renal system—kidney cancer	0.000806	0.0238	CbGeAlD
Tretinoin—ALDH1A1—kidney—kidney cancer	0.000779	0.023	CbGeAlD
Tretinoin—ALDH1A1—cortex of kidney—kidney cancer	0.000759	0.0224	CbGeAlD
Tretinoin—CYP3A4—urine—kidney cancer	0.000728	0.0215	CbGeAlD
Tretinoin—ALDH1A1—gonad—kidney cancer	0.000723	0.0214	CbGeAlD
Tretinoin—ALDH1A1—cardiac atrium—kidney cancer	0.000722	0.0213	CbGeAlD
Tretinoin—RXRB—cardiac atrium—kidney cancer	0.000712	0.0211	CbGeAlD
Tretinoin—RARA—renal system—kidney cancer	0.000664	0.0196	CbGeAlD
Tretinoin—RARA—kidney—kidney cancer	0.000641	0.019	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000631	0.0186	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Doxorubicin—kidney cancer	0.000628	0.412	CbGdCrCtD
Tretinoin—RARA—gonad—kidney cancer	0.000595	0.0176	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00054	0.016	CbGeAlD
Tretinoin—CYP2C8—renal system—kidney cancer	0.000263	0.00777	CbGeAlD
Tretinoin—CYP3A5—nephron tubule—kidney cancer	0.000261	0.00772	CbGeAlD
Tretinoin—CYP2B6—nephron tubule—kidney cancer	0.000259	0.00767	CbGeAlD
Tretinoin—CYP2C8—kidney—kidney cancer	0.000254	0.00751	CbGeAlD
Tretinoin—CYP1A1—renal system—kidney cancer	0.000243	0.00717	CbGeAlD
Tretinoin—CYP3A5—renal system—kidney cancer	0.000237	0.00702	CbGeAlD
Tretinoin—CYP2B6—renal system—kidney cancer	0.000236	0.00697	CbGeAlD
Tretinoin—CYP1A1—kidney—kidney cancer	0.000235	0.00694	CbGeAlD
Tretinoin—CYP3A5—kidney—kidney cancer	0.000229	0.00678	CbGeAlD
Tretinoin—CYP2B6—kidney—kidney cancer	0.000228	0.00674	CbGeAlD
Tretinoin—CYP3A5—cortex of kidney—kidney cancer	0.000223	0.0066	CbGeAlD
Tretinoin—CYP1A1—cardiac atrium—kidney cancer	0.000217	0.00643	CbGeAlD
Tretinoin—CYP2B6—gonad—kidney cancer	0.000211	0.00625	CbGeAlD
Tretinoin—CYP3A4—renal system—kidney cancer	0.000178	0.00526	CbGeAlD
Tretinoin—CYP3A4—kidney—kidney cancer	0.000172	0.00509	CbGeAlD
Tretinoin—Vitamin A—CYP1A1—kidney cancer	0.00017	0.0547	CrCbGaD
Tretinoin—Alitretinoin—ABCB1—kidney cancer	0.000124	0.0398	CrCbGaD
Tretinoin—Nausea—Erlotinib—kidney cancer	2.63e-05	0.000205	CcSEcCtD
Tretinoin—Alopecia—Capecitabine—kidney cancer	2.62e-05	0.000205	CcSEcCtD
Tretinoin—Dry mouth—Paclitaxel—kidney cancer	2.62e-05	0.000205	CcSEcCtD
Tretinoin—Mood swings—Doxorubicin—kidney cancer	2.62e-05	0.000204	CcSEcCtD
Tretinoin—Diarrhoea—Sunitinib—kidney cancer	2.62e-05	0.000204	CcSEcCtD
Tretinoin—Mental disorder—Capecitabine—kidney cancer	2.6e-05	0.000203	CcSEcCtD
Tretinoin—Asthenia—Dactinomycin—kidney cancer	2.6e-05	0.000203	CcSEcCtD
Tretinoin—Confusional state—Paclitaxel—kidney cancer	2.59e-05	0.000202	CcSEcCtD
Tretinoin—Blood creatinine increased—Doxorubicin—kidney cancer	2.59e-05	0.000202	CcSEcCtD
Tretinoin—Malnutrition—Capecitabine—kidney cancer	2.59e-05	0.000202	CcSEcCtD
Tretinoin—Erythema—Capecitabine—kidney cancer	2.59e-05	0.000202	CcSEcCtD
Tretinoin—Dehydration—Doxorubicin—kidney cancer	2.57e-05	0.000201	CcSEcCtD
Tretinoin—Oedema—Paclitaxel—kidney cancer	2.57e-05	0.000201	CcSEcCtD
Tretinoin—Anaphylactic shock—Paclitaxel—kidney cancer	2.57e-05	0.000201	CcSEcCtD
Tretinoin—Abdominal pain—Vincristine—kidney cancer	2.56e-05	0.0002	CcSEcCtD
Tretinoin—Body temperature increased—Vincristine—kidney cancer	2.56e-05	0.0002	CcSEcCtD
Tretinoin—Infection—Paclitaxel—kidney cancer	2.55e-05	0.000199	CcSEcCtD
Tretinoin—Flatulence—Capecitabine—kidney cancer	2.55e-05	0.000199	CcSEcCtD
Tretinoin—Dry skin—Doxorubicin—kidney cancer	2.54e-05	0.000198	CcSEcCtD
Tretinoin—Dizziness—Sunitinib—kidney cancer	2.53e-05	0.000197	CcSEcCtD
Tretinoin—Feeling abnormal—Gemcitabine—kidney cancer	2.53e-05	0.000197	CcSEcCtD
Tretinoin—Shock—Paclitaxel—kidney cancer	2.53e-05	0.000197	CcSEcCtD
Tretinoin—Vomiting—Sorafenib—kidney cancer	2.53e-05	0.000197	CcSEcCtD
Tretinoin—Nervous system disorder—Paclitaxel—kidney cancer	2.52e-05	0.000197	CcSEcCtD
Tretinoin—Thrombocytopenia—Paclitaxel—kidney cancer	2.52e-05	0.000196	CcSEcCtD
Tretinoin—Tachycardia—Paclitaxel—kidney cancer	2.51e-05	0.000196	CcSEcCtD
Tretinoin—Rash—Sorafenib—kidney cancer	2.51e-05	0.000196	CcSEcCtD
Tretinoin—Dermatitis—Sorafenib—kidney cancer	2.51e-05	0.000195	CcSEcCtD
Tretinoin—Back pain—Capecitabine—kidney cancer	2.5e-05	0.000195	CcSEcCtD
Tretinoin—Skin disorder—Paclitaxel—kidney cancer	2.5e-05	0.000195	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	2.49e-05	0.000194	CcSEcCtD
Tretinoin—Headache—Sorafenib—kidney cancer	2.49e-05	0.000194	CcSEcCtD
Tretinoin—Hyperhidrosis—Paclitaxel—kidney cancer	2.49e-05	0.000194	CcSEcCtD
Tretinoin—Diarrhoea—Dactinomycin—kidney cancer	2.48e-05	0.000193	CcSEcCtD
Tretinoin—Nasopharyngitis—Doxorubicin—kidney cancer	2.48e-05	0.000193	CcSEcCtD
Tretinoin—Anorexia—Paclitaxel—kidney cancer	2.45e-05	0.000191	CcSEcCtD
Tretinoin—Gastritis—Doxorubicin—kidney cancer	2.45e-05	0.000191	CcSEcCtD
Tretinoin—Vision blurred—Capecitabine—kidney cancer	2.44e-05	0.00019	CcSEcCtD
Tretinoin—Vomiting—Sunitinib—kidney cancer	2.43e-05	0.00019	CcSEcCtD
Tretinoin—Body temperature increased—Gemcitabine—kidney cancer	2.43e-05	0.000189	CcSEcCtD
Tretinoin—Tremor—Capecitabine—kidney cancer	2.42e-05	0.000189	CcSEcCtD
Tretinoin—Rash—Sunitinib—kidney cancer	2.41e-05	0.000188	CcSEcCtD
Tretinoin—Dermatitis—Sunitinib—kidney cancer	2.41e-05	0.000188	CcSEcCtD
Tretinoin—Abdominal distension—Doxorubicin—kidney cancer	2.41e-05	0.000188	CcSEcCtD
Tretinoin—Hypotension—Paclitaxel—kidney cancer	2.4e-05	0.000187	CcSEcCtD
Tretinoin—Ill-defined disorder—Capecitabine—kidney cancer	2.4e-05	0.000187	CcSEcCtD
Tretinoin—Headache—Sunitinib—kidney cancer	2.4e-05	0.000187	CcSEcCtD
Tretinoin—Dysphagia—Doxorubicin—kidney cancer	2.39e-05	0.000187	CcSEcCtD
Tretinoin—Asthma—Doxorubicin—kidney cancer	2.39e-05	0.000187	CcSEcCtD
Tretinoin—Anaemia—Capecitabine—kidney cancer	2.39e-05	0.000186	CcSEcCtD
Tretinoin—Hypersensitivity—Vincristine—kidney cancer	2.39e-05	0.000186	CcSEcCtD
Tretinoin—Nausea—Sorafenib—kidney cancer	2.36e-05	0.000184	CcSEcCtD
Tretinoin—Pancreatitis—Doxorubicin—kidney cancer	2.35e-05	0.000183	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.34e-05	0.000183	CcSEcCtD
Tretinoin—Malaise—Capecitabine—kidney cancer	2.33e-05	0.000182	CcSEcCtD
Tretinoin—Insomnia—Paclitaxel—kidney cancer	2.33e-05	0.000181	CcSEcCtD
Tretinoin—Asthenia—Vincristine—kidney cancer	2.32e-05	0.000181	CcSEcCtD
Tretinoin—Syncope—Capecitabine—kidney cancer	2.32e-05	0.000181	CcSEcCtD
Tretinoin—Paraesthesia—Paclitaxel—kidney cancer	2.31e-05	0.00018	CcSEcCtD
Tretinoin—Vomiting—Dactinomycin—kidney cancer	2.3e-05	0.00018	CcSEcCtD
Tretinoin—Dyspnoea—Paclitaxel—kidney cancer	2.29e-05	0.000179	CcSEcCtD
Tretinoin—Somnolence—Paclitaxel—kidney cancer	2.29e-05	0.000178	CcSEcCtD
Tretinoin—Palpitations—Capecitabine—kidney cancer	2.29e-05	0.000178	CcSEcCtD
Tretinoin—Rash—Dactinomycin—kidney cancer	2.28e-05	0.000178	CcSEcCtD
Tretinoin—Nausea—Sunitinib—kidney cancer	2.27e-05	0.000177	CcSEcCtD
Tretinoin—Loss of consciousness—Capecitabine—kidney cancer	2.27e-05	0.000177	CcSEcCtD
Tretinoin—Dyspepsia—Paclitaxel—kidney cancer	2.26e-05	0.000177	CcSEcCtD
Tretinoin—Cough—Capecitabine—kidney cancer	2.26e-05	0.000176	CcSEcCtD
Tretinoin—Dysuria—Doxorubicin—kidney cancer	2.24e-05	0.000174	CcSEcCtD
Tretinoin—Neutropenia—Doxorubicin—kidney cancer	2.24e-05	0.000174	CcSEcCtD
Tretinoin—Decreased appetite—Paclitaxel—kidney cancer	2.24e-05	0.000174	CcSEcCtD
Tretinoin—Hypertension—Capecitabine—kidney cancer	2.23e-05	0.000174	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Doxorubicin—kidney cancer	2.22e-05	0.000173	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.22e-05	0.000173	CcSEcCtD
Tretinoin—Fatigue—Paclitaxel—kidney cancer	2.22e-05	0.000173	CcSEcCtD
Tretinoin—Diarrhoea—Vincristine—kidney cancer	2.22e-05	0.000173	CcSEcCtD
Tretinoin—Pollakiuria—Doxorubicin—kidney cancer	2.21e-05	0.000172	CcSEcCtD
Tretinoin—Asthenia—Gemcitabine—kidney cancer	2.2e-05	0.000172	CcSEcCtD
Tretinoin—Arthralgia—Capecitabine—kidney cancer	2.2e-05	0.000172	CcSEcCtD
Tretinoin—Chest pain—Capecitabine—kidney cancer	2.2e-05	0.000172	CcSEcCtD
Tretinoin—Myalgia—Capecitabine—kidney cancer	2.2e-05	0.000172	CcSEcCtD
Tretinoin—Constipation—Paclitaxel—kidney cancer	2.2e-05	0.000171	CcSEcCtD
Tretinoin—Pain—Paclitaxel—kidney cancer	2.2e-05	0.000171	CcSEcCtD
Tretinoin—Anxiety—Capecitabine—kidney cancer	2.19e-05	0.000171	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.19e-05	0.00017	CcSEcCtD
Tretinoin—Photosensitivity reaction—Doxorubicin—kidney cancer	2.18e-05	0.00017	CcSEcCtD
Tretinoin—Weight increased—Doxorubicin—kidney cancer	2.18e-05	0.00017	CcSEcCtD
Tretinoin—Discomfort—Capecitabine—kidney cancer	2.18e-05	0.00017	CcSEcCtD
Tretinoin—Pruritus—Gemcitabine—kidney cancer	2.17e-05	0.000169	CcSEcCtD
Tretinoin—Weight decreased—Doxorubicin—kidney cancer	2.16e-05	0.000169	CcSEcCtD
Tretinoin—Dry mouth—Capecitabine—kidney cancer	2.15e-05	0.000168	CcSEcCtD
Tretinoin—Nausea—Dactinomycin—kidney cancer	2.15e-05	0.000168	CcSEcCtD
Tretinoin—Pneumonia—Doxorubicin—kidney cancer	2.15e-05	0.000167	CcSEcCtD
Tretinoin—Dizziness—Vincristine—kidney cancer	2.14e-05	0.000167	CcSEcCtD
Tretinoin—Drowsiness—Doxorubicin—kidney cancer	2.13e-05	0.000166	CcSEcCtD
Tretinoin—Infestation NOS—Doxorubicin—kidney cancer	2.13e-05	0.000166	CcSEcCtD
Tretinoin—Infestation—Doxorubicin—kidney cancer	2.13e-05	0.000166	CcSEcCtD
Tretinoin—Confusional state—Capecitabine—kidney cancer	2.13e-05	0.000166	CcSEcCtD
Tretinoin—Feeling abnormal—Paclitaxel—kidney cancer	2.12e-05	0.000165	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	2.11e-05	0.000165	CcSEcCtD
Tretinoin—Oedema—Capecitabine—kidney cancer	2.11e-05	0.000165	CcSEcCtD
Tretinoin—Gastrointestinal pain—Paclitaxel—kidney cancer	2.1e-05	0.000164	CcSEcCtD
Tretinoin—Diarrhoea—Gemcitabine—kidney cancer	2.1e-05	0.000164	CcSEcCtD
Tretinoin—Renal failure—Doxorubicin—kidney cancer	2.1e-05	0.000163	CcSEcCtD
Tretinoin—Infection—Capecitabine—kidney cancer	2.1e-05	0.000163	CcSEcCtD
Tretinoin—Neuropathy peripheral—Doxorubicin—kidney cancer	2.09e-05	0.000163	CcSEcCtD
Tretinoin—Stomatitis—Doxorubicin—kidney cancer	2.08e-05	0.000162	CcSEcCtD
Tretinoin—Shock—Capecitabine—kidney cancer	2.08e-05	0.000162	CcSEcCtD
Tretinoin—Conjunctivitis—Doxorubicin—kidney cancer	2.07e-05	0.000162	CcSEcCtD
Tretinoin—Urinary tract infection—Doxorubicin—kidney cancer	2.07e-05	0.000162	CcSEcCtD
Tretinoin—Nervous system disorder—Capecitabine—kidney cancer	2.07e-05	0.000161	CcSEcCtD
Tretinoin—Thrombocytopenia—Capecitabine—kidney cancer	2.07e-05	0.000161	CcSEcCtD
Tretinoin—Tachycardia—Capecitabine—kidney cancer	2.06e-05	0.000161	CcSEcCtD
Tretinoin—Vomiting—Vincristine—kidney cancer	2.06e-05	0.000161	CcSEcCtD
Tretinoin—Skin disorder—Capecitabine—kidney cancer	2.05e-05	0.00016	CcSEcCtD
Tretinoin—Sweating—Doxorubicin—kidney cancer	2.04e-05	0.000159	CcSEcCtD
Tretinoin—Urticaria—Paclitaxel—kidney cancer	2.04e-05	0.000159	CcSEcCtD
Tretinoin—Rash—Vincristine—kidney cancer	2.04e-05	0.000159	CcSEcCtD
Tretinoin—Hyperhidrosis—Capecitabine—kidney cancer	2.04e-05	0.000159	CcSEcCtD
Tretinoin—Dermatitis—Vincristine—kidney cancer	2.04e-05	0.000159	CcSEcCtD
Tretinoin—Haematuria—Doxorubicin—kidney cancer	2.03e-05	0.000159	CcSEcCtD
Tretinoin—Abdominal pain—Paclitaxel—kidney cancer	2.03e-05	0.000159	CcSEcCtD
Tretinoin—Body temperature increased—Paclitaxel—kidney cancer	2.03e-05	0.000159	CcSEcCtD
Tretinoin—Headache—Vincristine—kidney cancer	2.03e-05	0.000158	CcSEcCtD
Tretinoin—Epistaxis—Doxorubicin—kidney cancer	2.01e-05	0.000157	CcSEcCtD
Tretinoin—Anorexia—Capecitabine—kidney cancer	2.01e-05	0.000157	CcSEcCtD
Tretinoin—Sinusitis—Doxorubicin—kidney cancer	2e-05	0.000156	CcSEcCtD
Tretinoin—Agranulocytosis—Doxorubicin—kidney cancer	1.99e-05	0.000155	CcSEcCtD
Tretinoin—Hypotension—Capecitabine—kidney cancer	1.97e-05	0.000154	CcSEcCtD
Tretinoin—Vomiting—Gemcitabine—kidney cancer	1.95e-05	0.000152	CcSEcCtD
Tretinoin—Rash—Gemcitabine—kidney cancer	1.94e-05	0.000151	CcSEcCtD
Tretinoin—Dermatitis—Gemcitabine—kidney cancer	1.93e-05	0.000151	CcSEcCtD
Tretinoin—Haemoglobin—Doxorubicin—kidney cancer	1.92e-05	0.00015	CcSEcCtD
Tretinoin—Headache—Gemcitabine—kidney cancer	1.92e-05	0.00015	CcSEcCtD
Tretinoin—Nausea—Vincristine—kidney cancer	1.92e-05	0.00015	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.92e-05	0.00015	CcSEcCtD
Tretinoin—Hepatitis—Doxorubicin—kidney cancer	1.91e-05	0.000149	CcSEcCtD
Tretinoin—Haemorrhage—Doxorubicin—kidney cancer	1.91e-05	0.000149	CcSEcCtD
Tretinoin—Insomnia—Capecitabine—kidney cancer	1.91e-05	0.000149	CcSEcCtD
Tretinoin—Hypoaesthesia—Doxorubicin—kidney cancer	1.91e-05	0.000149	CcSEcCtD
Tretinoin—Pharyngitis—Doxorubicin—kidney cancer	1.9e-05	0.000148	CcSEcCtD
Tretinoin—Paraesthesia—Capecitabine—kidney cancer	1.9e-05	0.000148	CcSEcCtD
Tretinoin—Hypersensitivity—Paclitaxel—kidney cancer	1.89e-05	0.000148	CcSEcCtD
Tretinoin—Urinary tract disorder—Doxorubicin—kidney cancer	1.89e-05	0.000147	CcSEcCtD
Tretinoin—Oedema peripheral—Doxorubicin—kidney cancer	1.89e-05	0.000147	CcSEcCtD
Tretinoin—Dyspnoea—Capecitabine—kidney cancer	1.88e-05	0.000147	CcSEcCtD
Tretinoin—Urethral disorder—Doxorubicin—kidney cancer	1.88e-05	0.000146	CcSEcCtD
Tretinoin—Dyspepsia—Capecitabine—kidney cancer	1.86e-05	0.000145	CcSEcCtD
Tretinoin—Visual impairment—Doxorubicin—kidney cancer	1.85e-05	0.000144	CcSEcCtD
Tretinoin—Asthenia—Paclitaxel—kidney cancer	1.85e-05	0.000144	CcSEcCtD
Tretinoin—Decreased appetite—Capecitabine—kidney cancer	1.83e-05	0.000143	CcSEcCtD
Tretinoin—Nausea—Gemcitabine—kidney cancer	1.82e-05	0.000142	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Capecitabine—kidney cancer	1.82e-05	0.000142	CcSEcCtD
Tretinoin—Fatigue—Capecitabine—kidney cancer	1.82e-05	0.000142	CcSEcCtD
Tretinoin—Pruritus—Paclitaxel—kidney cancer	1.82e-05	0.000142	CcSEcCtD
Tretinoin—Erythema multiforme—Doxorubicin—kidney cancer	1.81e-05	0.000141	CcSEcCtD
Tretinoin—Constipation—Capecitabine—kidney cancer	1.8e-05	0.000141	CcSEcCtD
Tretinoin—Pain—Capecitabine—kidney cancer	1.8e-05	0.000141	CcSEcCtD
Tretinoin—Eye disorder—Doxorubicin—kidney cancer	1.79e-05	0.00014	CcSEcCtD
Tretinoin—Tinnitus—Doxorubicin—kidney cancer	1.79e-05	0.000139	CcSEcCtD
Tretinoin—Flushing—Doxorubicin—kidney cancer	1.78e-05	0.000139	CcSEcCtD
Tretinoin—Diarrhoea—Paclitaxel—kidney cancer	1.76e-05	0.000137	CcSEcCtD
Tretinoin—Feeling abnormal—Capecitabine—kidney cancer	1.74e-05	0.000136	CcSEcCtD
Tretinoin—Angiopathy—Doxorubicin—kidney cancer	1.74e-05	0.000135	CcSEcCtD
Tretinoin—Gastrointestinal pain—Capecitabine—kidney cancer	1.73e-05	0.000135	CcSEcCtD
Tretinoin—Chills—Doxorubicin—kidney cancer	1.72e-05	0.000134	CcSEcCtD
Tretinoin—Arrhythmia—Doxorubicin—kidney cancer	1.71e-05	0.000133	CcSEcCtD
Tretinoin—Dizziness—Paclitaxel—kidney cancer	1.7e-05	0.000133	CcSEcCtD
Tretinoin—Alopecia—Doxorubicin—kidney cancer	1.69e-05	0.000132	CcSEcCtD
Tretinoin—Mental disorder—Doxorubicin—kidney cancer	1.68e-05	0.000131	CcSEcCtD
Tretinoin—Urticaria—Capecitabine—kidney cancer	1.68e-05	0.000131	CcSEcCtD
Tretinoin—Body temperature increased—Capecitabine—kidney cancer	1.67e-05	0.00013	CcSEcCtD
Tretinoin—Abdominal pain—Capecitabine—kidney cancer	1.67e-05	0.00013	CcSEcCtD
Tretinoin—Malnutrition—Doxorubicin—kidney cancer	1.67e-05	0.00013	CcSEcCtD
Tretinoin—Erythema—Doxorubicin—kidney cancer	1.67e-05	0.00013	CcSEcCtD
Tretinoin—Flatulence—Doxorubicin—kidney cancer	1.64e-05	0.000128	CcSEcCtD
Tretinoin—Tension—Doxorubicin—kidney cancer	1.64e-05	0.000128	CcSEcCtD
Tretinoin—Vomiting—Paclitaxel—kidney cancer	1.64e-05	0.000127	CcSEcCtD
Tretinoin—Rash—Paclitaxel—kidney cancer	1.62e-05	0.000126	CcSEcCtD
Tretinoin—Dermatitis—Paclitaxel—kidney cancer	1.62e-05	0.000126	CcSEcCtD
Tretinoin—Nervousness—Doxorubicin—kidney cancer	1.62e-05	0.000126	CcSEcCtD
Tretinoin—Back pain—Doxorubicin—kidney cancer	1.61e-05	0.000126	CcSEcCtD
Tretinoin—Headache—Paclitaxel—kidney cancer	1.61e-05	0.000126	CcSEcCtD
Tretinoin—Vision blurred—Doxorubicin—kidney cancer	1.57e-05	0.000122	CcSEcCtD
Tretinoin—Hypersensitivity—Capecitabine—kidney cancer	1.55e-05	0.000121	CcSEcCtD
Tretinoin—Ill-defined disorder—Doxorubicin—kidney cancer	1.55e-05	0.000121	CcSEcCtD
Tretinoin—Anaemia—Doxorubicin—kidney cancer	1.54e-05	0.00012	CcSEcCtD
Tretinoin—Agitation—Doxorubicin—kidney cancer	1.53e-05	0.000119	CcSEcCtD
Tretinoin—Nausea—Paclitaxel—kidney cancer	1.53e-05	0.000119	CcSEcCtD
Tretinoin—Asthenia—Capecitabine—kidney cancer	1.51e-05	0.000118	CcSEcCtD
Tretinoin—Malaise—Doxorubicin—kidney cancer	1.5e-05	0.000117	CcSEcCtD
Tretinoin—Syncope—Doxorubicin—kidney cancer	1.49e-05	0.000117	CcSEcCtD
Tretinoin—Pruritus—Capecitabine—kidney cancer	1.49e-05	0.000116	CcSEcCtD
Tretinoin—Palpitations—Doxorubicin—kidney cancer	1.47e-05	0.000115	CcSEcCtD
Tretinoin—Loss of consciousness—Doxorubicin—kidney cancer	1.47e-05	0.000114	CcSEcCtD
Tretinoin—Cough—Doxorubicin—kidney cancer	1.45e-05	0.000113	CcSEcCtD
Tretinoin—Convulsion—Doxorubicin—kidney cancer	1.44e-05	0.000113	CcSEcCtD
Tretinoin—Diarrhoea—Capecitabine—kidney cancer	1.44e-05	0.000113	CcSEcCtD
Tretinoin—Hypertension—Doxorubicin—kidney cancer	1.44e-05	0.000112	CcSEcCtD
Tretinoin—Chest pain—Doxorubicin—kidney cancer	1.42e-05	0.000111	CcSEcCtD
Tretinoin—Arthralgia—Doxorubicin—kidney cancer	1.42e-05	0.000111	CcSEcCtD
Tretinoin—Myalgia—Doxorubicin—kidney cancer	1.42e-05	0.000111	CcSEcCtD
Tretinoin—Anxiety—Doxorubicin—kidney cancer	1.41e-05	0.00011	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.41e-05	0.00011	CcSEcCtD
Tretinoin—Discomfort—Doxorubicin—kidney cancer	1.4e-05	0.000109	CcSEcCtD
Tretinoin—Dizziness—Capecitabine—kidney cancer	1.4e-05	0.000109	CcSEcCtD
Tretinoin—Dry mouth—Doxorubicin—kidney cancer	1.39e-05	0.000108	CcSEcCtD
Tretinoin—Confusional state—Doxorubicin—kidney cancer	1.37e-05	0.000107	CcSEcCtD
Tretinoin—Oedema—Doxorubicin—kidney cancer	1.36e-05	0.000106	CcSEcCtD
Tretinoin—Anaphylactic shock—Doxorubicin—kidney cancer	1.36e-05	0.000106	CcSEcCtD
Tretinoin—Infection—Doxorubicin—kidney cancer	1.35e-05	0.000105	CcSEcCtD
Tretinoin—Vomiting—Capecitabine—kidney cancer	1.34e-05	0.000105	CcSEcCtD
Tretinoin—Shock—Doxorubicin—kidney cancer	1.34e-05	0.000104	CcSEcCtD
Tretinoin—Nervous system disorder—Doxorubicin—kidney cancer	1.33e-05	0.000104	CcSEcCtD
Tretinoin—Thrombocytopenia—Doxorubicin—kidney cancer	1.33e-05	0.000104	CcSEcCtD
Tretinoin—Rash—Capecitabine—kidney cancer	1.33e-05	0.000104	CcSEcCtD
Tretinoin—Dermatitis—Capecitabine—kidney cancer	1.33e-05	0.000104	CcSEcCtD
Tretinoin—Tachycardia—Doxorubicin—kidney cancer	1.33e-05	0.000104	CcSEcCtD
Tretinoin—Headache—Capecitabine—kidney cancer	1.32e-05	0.000103	CcSEcCtD
Tretinoin—Skin disorder—Doxorubicin—kidney cancer	1.32e-05	0.000103	CcSEcCtD
Tretinoin—Hyperhidrosis—Doxorubicin—kidney cancer	1.32e-05	0.000103	CcSEcCtD
Tretinoin—Anorexia—Doxorubicin—kidney cancer	1.3e-05	0.000101	CcSEcCtD
Tretinoin—Hypotension—Doxorubicin—kidney cancer	1.27e-05	9.91e-05	CcSEcCtD
Tretinoin—Nausea—Capecitabine—kidney cancer	1.25e-05	9.77e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.24e-05	9.66e-05	CcSEcCtD
Tretinoin—Insomnia—Doxorubicin—kidney cancer	1.23e-05	9.59e-05	CcSEcCtD
Tretinoin—Paraesthesia—Doxorubicin—kidney cancer	1.22e-05	9.52e-05	CcSEcCtD
Tretinoin—Dyspnoea—Doxorubicin—kidney cancer	1.21e-05	9.46e-05	CcSEcCtD
Tretinoin—Somnolence—Doxorubicin—kidney cancer	1.21e-05	9.43e-05	CcSEcCtD
Tretinoin—Dyspepsia—Doxorubicin—kidney cancer	1.2e-05	9.34e-05	CcSEcCtD
Tretinoin—Decreased appetite—Doxorubicin—kidney cancer	1.18e-05	9.22e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.17e-05	9.16e-05	CcSEcCtD
Tretinoin—Fatigue—Doxorubicin—kidney cancer	1.17e-05	9.14e-05	CcSEcCtD
Tretinoin—Constipation—Doxorubicin—kidney cancer	1.16e-05	9.07e-05	CcSEcCtD
Tretinoin—Pain—Doxorubicin—kidney cancer	1.16e-05	9.07e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Doxorubicin—kidney cancer	1.12e-05	8.74e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Doxorubicin—kidney cancer	1.11e-05	8.67e-05	CcSEcCtD
Tretinoin—Urticaria—Doxorubicin—kidney cancer	1.08e-05	8.43e-05	CcSEcCtD
Tretinoin—Body temperature increased—Doxorubicin—kidney cancer	1.08e-05	8.38e-05	CcSEcCtD
Tretinoin—Abdominal pain—Doxorubicin—kidney cancer	1.08e-05	8.38e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Doxorubicin—kidney cancer	1e-05	7.81e-05	CcSEcCtD
Tretinoin—Asthenia—Doxorubicin—kidney cancer	9.76e-06	7.61e-05	CcSEcCtD
Tretinoin—Pruritus—Doxorubicin—kidney cancer	9.62e-06	7.5e-05	CcSEcCtD
Tretinoin—Diarrhoea—Doxorubicin—kidney cancer	9.31e-06	7.26e-05	CcSEcCtD
Tretinoin—Dizziness—Doxorubicin—kidney cancer	9e-06	7.01e-05	CcSEcCtD
Tretinoin—Vomiting—Doxorubicin—kidney cancer	8.65e-06	6.74e-05	CcSEcCtD
Tretinoin—Rash—Doxorubicin—kidney cancer	8.58e-06	6.69e-05	CcSEcCtD
Tretinoin—Dermatitis—Doxorubicin—kidney cancer	8.57e-06	6.68e-05	CcSEcCtD
Tretinoin—Headache—Doxorubicin—kidney cancer	8.52e-06	6.64e-05	CcSEcCtD
Tretinoin—Nausea—Doxorubicin—kidney cancer	8.08e-06	6.3e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism—ALAD—kidney cancer	5.18e-06	6.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PGK1—kidney cancer	5.17e-06	6.94e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC5A3—kidney cancer	5.17e-06	6.94e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CTNNB1—kidney cancer	5.11e-06	6.86e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.1e-06	6.85e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPAT—kidney cancer	5.09e-06	6.83e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GLIPR1—kidney cancer	5.09e-06	6.83e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ITPR2—kidney cancer	5.09e-06	6.83e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GSTM1—kidney cancer	5.08e-06	6.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—LDHB—kidney cancer	5.07e-06	6.8e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ST3GAL2—kidney cancer	5.06e-06	6.79e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.02e-06	6.74e-05	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—RAF1—kidney cancer	5.02e-06	6.73e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CRABP1—kidney cancer	5.01e-06	6.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.97e-06	6.67e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALDH1A1—kidney cancer	4.94e-06	6.63e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MAPK3—kidney cancer	4.86e-06	6.52e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ACY1—kidney cancer	4.84e-06	6.5e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSTP1—kidney cancer	4.84e-06	6.49e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP1A1—kidney cancer	4.82e-06	6.47e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CA9—kidney cancer	4.76e-06	6.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PGK1—kidney cancer	4.74e-06	6.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC5A3—kidney cancer	4.74e-06	6.36e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APRT—kidney cancer	4.73e-06	6.35e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—FH—kidney cancer	4.73e-06	6.35e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—kidney cancer	4.73e-06	6.35e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ITPR2—kidney cancer	4.66e-06	6.26e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CA9—kidney cancer	4.65e-06	6.24e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LDHB—kidney cancer	4.65e-06	6.24e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTT1—kidney cancer	4.64e-06	6.23e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ACHE—kidney cancer	4.64e-06	6.23e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.62e-06	6.21e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PIK3CA—kidney cancer	4.62e-06	6.2e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PIK3CA—kidney cancer	4.62e-06	6.2e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PIK3CA—kidney cancer	4.62e-06	6.2e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ABCB1—kidney cancer	4.58e-06	6.14e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—kidney cancer	4.5e-06	6.04e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.45e-06	5.98e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPC3—kidney cancer	4.45e-06	5.97e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MAPK3—kidney cancer	4.45e-06	5.97e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSTM1—kidney cancer	4.44e-06	5.96e-05	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—kidney cancer	4.4e-06	5.91e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CA9—kidney cancer	4.39e-06	5.9e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SCARB1—kidney cancer	4.39e-06	5.89e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTP1—kidney cancer	4.39e-06	5.89e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MAPK3—kidney cancer	4.36e-06	5.85e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS1—kidney cancer	4.35e-06	5.83e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CA2—kidney cancer	4.33e-06	5.81e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MYC—kidney cancer	4.32e-06	5.8e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PSMD7—kidney cancer	4.26e-06	5.72e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MAPK3—kidney cancer	4.26e-06	5.72e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTT1—kidney cancer	4.25e-06	5.71e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ACHE—kidney cancer	4.25e-06	5.71e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MYC—kidney cancer	4.24e-06	5.69e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALAD—kidney cancer	4.22e-06	5.66e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP1A1—kidney cancer	4.21e-06	5.65e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MAPK3—kidney cancer	4.18e-06	5.61e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MAPK3—kidney cancer	4.18e-06	5.61e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ABCB1—kidney cancer	4.15e-06	5.58e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PDHB—kidney cancer	4.12e-06	5.52e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ST3GAL2—kidney cancer	4.11e-06	5.52e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—POMC—kidney cancer	4.1e-06	5.51e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—kidney cancer	4.07e-06	5.46e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—kidney cancer	4.07e-06	5.46e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MAPK1—kidney cancer	4.05e-06	5.44e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CRABP1—kidney cancer	4.05e-06	5.43e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—BCHE—kidney cancer	4.04e-06	5.42e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTM1—kidney cancer	4.03e-06	5.41e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CA9—kidney cancer	4.03e-06	5.41e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SCARB1—kidney cancer	4.02e-06	5.4e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALDH1A1—kidney cancer	4.02e-06	5.4e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC5A5—kidney cancer	3.99e-06	5.36e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS1—kidney cancer	3.98e-06	5.35e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.96e-06	5.31e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CRABP1—kidney cancer	3.95e-06	5.31e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.94e-06	5.28e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PSMD7—kidney cancer	3.91e-06	5.24e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CCBL1—kidney cancer	3.87e-06	5.19e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PGK1—kidney cancer	3.86e-06	5.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.86e-06	5.18e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC2A1—kidney cancer	3.85e-06	5.17e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—KRAS—kidney cancer	3.83e-06	5.14e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP1A1—kidney cancer	3.82e-06	5.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LDHB—kidney cancer	3.78e-06	5.08e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ITPR2—kidney cancer	3.76e-06	5.05e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CRABP1—kidney cancer	3.74e-06	5.01e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—BCHE—kidney cancer	3.7e-06	4.97e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ITPR2—kidney cancer	3.68e-06	4.93e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC5A5—kidney cancer	3.66e-06	4.91e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—POMC—kidney cancer	3.59e-06	4.82e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC2A1—kidney cancer	3.53e-06	4.74e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ITPR2—kidney cancer	3.47e-06	4.66e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ACHE—kidney cancer	3.43e-06	4.6e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTT1—kidney cancer	3.43e-06	4.6e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CRABP1—kidney cancer	3.43e-06	4.6e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPAT—kidney cancer	3.36e-06	4.5e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.36e-06	4.5e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTT1—kidney cancer	3.35e-06	4.5e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ACHE—kidney cancer	3.35e-06	4.5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CA9—kidney cancer	3.28e-06	4.4e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SCARB1—kidney cancer	3.25e-06	4.36e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTP1—kidney cancer	3.21e-06	4.32e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS1—kidney cancer	3.21e-06	4.31e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.2e-06	4.3e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.2e-06	4.3e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ITPR2—kidney cancer	3.18e-06	4.27e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SCARB1—kidney cancer	3.17e-06	4.26e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ACHE—kidney cancer	3.17e-06	4.25e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTT1—kidney cancer	3.17e-06	4.25e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PSMD7—kidney cancer	3.15e-06	4.23e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS1—kidney cancer	3.14e-06	4.22e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—POMC—kidney cancer	3.14e-06	4.22e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.14e-06	4.22e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APRT—kidney cancer	3.12e-06	4.19e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—FH—kidney cancer	3.12e-06	4.19e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PSMD7—kidney cancer	3.08e-06	4.14e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ABCB1—kidney cancer	3.04e-06	4.08e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SCARB1—kidney cancer	3e-06	4.02e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—BCHE—kidney cancer	2.99e-06	4.01e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS1—kidney cancer	2.97e-06	3.98e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTM1—kidney cancer	2.95e-06	3.97e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC5A5—kidney cancer	2.95e-06	3.96e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTP1—kidney cancer	2.95e-06	3.96e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.94e-06	3.94e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPC3—kidney cancer	2.93e-06	3.94e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—BCHE—kidney cancer	2.92e-06	3.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PSMD7—kidney cancer	2.91e-06	3.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ACHE—kidney cancer	2.9e-06	3.9e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTT1—kidney cancer	2.9e-06	3.9e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC5A5—kidney cancer	2.88e-06	3.87e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—kidney cancer	2.87e-06	3.85e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA2—kidney cancer	2.85e-06	3.83e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.85e-06	3.83e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—POMC—kidney cancer	2.85e-06	3.83e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1A1—kidney cancer	2.8e-06	3.76e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ABCB1—kidney cancer	2.79e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CRABP1—kidney cancer	2.79e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.79e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALAD—kidney cancer	2.78e-06	3.73e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—BCHE—kidney cancer	2.76e-06	3.7e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SCARB1—kidney cancer	2.75e-06	3.69e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC5A5—kidney cancer	2.73e-06	3.66e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS1—kidney cancer	2.72e-06	3.65e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.71e-06	3.64e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTM1—kidney cancer	2.71e-06	3.63e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PSMD7—kidney cancer	2.67e-06	3.58e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.65e-06	3.56e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC2A1—kidney cancer	2.63e-06	3.53e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ITPR2—kidney cancer	2.59e-06	3.48e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1A1—kidney cancer	2.57e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.55e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PGK1—kidney cancer	2.54e-06	3.41e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.54e-06	3.41e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—BCHE—kidney cancer	2.53e-06	3.4e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—kidney cancer	2.51e-06	3.36e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTEN—kidney cancer	2.5e-06	3.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.5e-06	3.35e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LDHB—kidney cancer	2.49e-06	3.35e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.41e-06	3.24e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.39e-06	3.21e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—kidney cancer	2.38e-06	3.19e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTT1—kidney cancer	2.36e-06	3.17e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ACHE—kidney cancer	2.36e-06	3.17e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.34e-06	3.14e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—kidney cancer	2.32e-06	3.12e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—kidney cancer	2.27e-06	3.05e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—kidney cancer	2.25e-06	3.02e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SCARB1—kidney cancer	2.24e-06	3e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.23e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS1—kidney cancer	2.21e-06	2.97e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—kidney cancer	2.2e-06	2.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—kidney cancer	2.2e-06	2.95e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—kidney cancer	2.18e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—kidney cancer	2.18e-06	2.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MAPK3—kidney cancer	2.18e-06	2.92e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PSMD7—kidney cancer	2.17e-06	2.92e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA9—kidney cancer	2.16e-06	2.9e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—kidney cancer	2.14e-06	2.87e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—kidney cancer	2.12e-06	2.84e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—POMC—kidney cancer	2.09e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—kidney cancer	2.08e-06	2.79e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A1—kidney cancer	2.07e-06	2.78e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BCHE—kidney cancer	2.06e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.04e-06	2.74e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.03e-06	2.73e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A1—kidney cancer	2.02e-06	2.72e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—kidney cancer	2.02e-06	2.71e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—kidney cancer	2.01e-06	2.7e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—kidney cancer	1.98e-06	2.66e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.96e-06	2.64e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—POMC—kidney cancer	1.91e-06	2.57e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.91e-06	2.56e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—kidney cancer	1.91e-06	2.56e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—kidney cancer	1.85e-06	2.48e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CRABP1—kidney cancer	1.84e-06	2.47e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—kidney cancer	1.76e-06	2.37e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.75e-06	2.35e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ITPR2—kidney cancer	1.71e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—kidney cancer	1.67e-06	2.24e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.66e-06	2.23e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—kidney cancer	1.64e-06	2.2e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.57e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTT1—kidney cancer	1.56e-06	2.09e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ACHE—kidney cancer	1.56e-06	2.09e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—kidney cancer	1.55e-06	2.08e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—POMC—kidney cancer	1.54e-06	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—kidney cancer	1.54e-06	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—kidney cancer	1.53e-06	2.05e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—POMC—kidney cancer	1.51e-06	2.03e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—kidney cancer	1.51e-06	2.02e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SCARB1—kidney cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS1—kidney cancer	1.46e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—kidney cancer	1.45e-06	1.95e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.44e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PSMD7—kidney cancer	1.43e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.43e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—POMC—kidney cancer	1.43e-06	1.91e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—kidney cancer	1.4e-06	1.88e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BCHE—kidney cancer	1.36e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.34e-06	1.8e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—kidney cancer	1.33e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—POMC—kidney cancer	1.31e-06	1.75e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.3e-06	1.74e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—kidney cancer	1.23e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—kidney cancer	1.2e-06	1.62e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.17e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—kidney cancer	1.14e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—kidney cancer	1.08e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—kidney cancer	1.07e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—POMC—kidney cancer	1.06e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—kidney cancer	1.05e-06	1.41e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—kidney cancer	1.04e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.02e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—kidney cancer	1.02e-06	1.37e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—kidney cancer	9.93e-07	1.33e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—kidney cancer	9.92e-07	1.33e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.41e-07	1.26e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—kidney cancer	9.39e-07	1.26e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—kidney cancer	9.09e-07	1.22e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—kidney cancer	8.49e-07	1.14e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—kidney cancer	7.58e-07	1.02e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—kidney cancer	7.41e-07	9.94e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—kidney cancer	7.4e-07	9.93e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—POMC—kidney cancer	7.02e-07	9.42e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—kidney cancer	7e-07	9.39e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—kidney cancer	6.42e-07	8.61e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—kidney cancer	5.6e-07	7.51e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—kidney cancer	5.22e-07	7.01e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—kidney cancer	4.88e-07	6.55e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.44e-07	4.62e-06	CbGpPWpGaD
